{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T15:48:29Z","timestamp":1744904909917,"version":"3.32.0"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We analyzed a shell vial culture assay (SVA), real-time PCR, and a direct fluorescent antibody assay (DFA) for rapid detection of vaccinia virus from vaccination sites of Dryvax vaccine recipients. Of 47 samples assayed, 100% were positive by PCR, 89% were positive by SVA, and 40% were positive by DFA. DFA was limited by the need for adequate numbers of cells, with 32% of samples inadequate for interpretation. DFA performed better with specimens from patients who had not previously received the vaccine. PCR was positive for longer times postvaccination than was SVA. Infectious virus could be recovered after 45 min of acetone fixation of shell vial coverslips. Commercially available polyclonal antibodies cross-reacted with other orthopoxviruses and herpes simplex 1, but commercially available monoclonal antibodies were specific for vaccinia virus. In summary, PCR was the most sensitive test for detecting vaccinia virus in clinical specimens, while the DFA was the most rapid but the least sensitive test.<\/jats:p>","DOI":"10.1128\/jcm.43.9.4602-4606.2005","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T21:58:02Z","timestamp":1126043882000},"page":"4602-4606","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":16,"title":["Comparison of Methods for Detection of Vaccinia Virus in Patient Specimens"],"prefix":"10.1128","volume":"43","author":[{"given":"Daniel P.","family":"Fedorko","sequence":"first","affiliation":[{"name":"Warren G. Magnuson Clinical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanne C.","family":"Preuss","sequence":"additional","affiliation":[{"name":"Warren G. Magnuson Clinical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary A.","family":"Fahle","sequence":"additional","affiliation":[{"name":"Warren G. Magnuson Clinical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Warren G. Magnuson Clinical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven H.","family":"Fischer","sequence":"additional","affiliation":[{"name":"Warren G. Magnuson Clinical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Hohman","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Infectious Diseases, National Institute for Allergy and Infectious Diseases, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, Maryland 20892"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(64)80642-9"},{"key":"e_1_3_2_3_2","first-page":"6","volume":"50","year":"2001","unstructured":"Centers for Disease Control and Prevention. 2001. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep.50(no. RR-10):6.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/381101"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.8.2165-2167.1997"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.1985-1988.2002"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.10.3860-3863.2000"},{"key":"e_1_3_2_8_2","first-page":"viii","volume":"120","year":"2003","unstructured":"Fulginiti, V. A. 2003. The risks of vaccinia in laboratory workers. J. Investig. Dermatol.120:viii.","journal-title":"J. Investig. Dermatol."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1086\/375824"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.09.013"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.3.1373-1375.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.2.601-609.2004"},{"key":"e_1_3_2_13_2","first-page":"137","year":"1977","unstructured":"Kurata, T., Y. Aoyama, and T. Kitamura. 1977. Demonstration of vaccinia virus antigen in brains of postvaccinal encephalitis cases. Jpn. J. Med. Sci. Biol.137-147.","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"e_1_3_2_14_2","first-page":"303","volume":"122","year":"1968","unstructured":"Lane, J. M., F. L. Ruben, J. M. Neff, and J. D. Millar. 1968. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J. Infect. Dis.122:303-309.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.2.490-494.2002"},{"key":"e_1_3_2_16_2","first-page":"134","volume":"29","year":"2003","unstructured":"Loeb, M., I. Zando, M. C. Orvidas, A. Bialachowski, D. Groves, and J. Mahoney. 2003. Laboratory-acquired vaccinia infection. Can. Commun. Dis. Rep.29:134-136.","journal-title":"Can. Commun. Dis. Rep."},{"key":"e_1_3_2_17_2","first-page":"214","volume":"21","year":"1976","unstructured":"Maltseva, N. N., and R. A. Nishanov. 1976. Application of the fluorescent antibodies method for rapid diagnosis caused of diseases by poxviruses. J. Hyg. Epidemiol. Microbiol. Immunol.21:214-220.","journal-title":"J. Hyg. Epidemiol. Microbiol. Immunol."},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12074.x"},{"key":"e_1_3_2_19_2","first-page":"160","volume":"3","year":"2000","unstructured":"Miller, C. G., C. Krummenacher, R. J. Eisenberg, G. H. Cohen, and N. W. Fraser. 2000. Development of a syngenic murine B16 cell line-derived melanoma susceptible to destruction by neuroattenuated HSV-1. Mol. Ther.3:160-168.","journal-title":"Mol. Ther."},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3201\/eid0906.020732","volume":"9","year":"2003","unstructured":"Moussatche, N., M. Tuyama, S. E. Kato, A. P. Castro, B. Njaine, R. H. Peralta, J. M. Peralta, C. R. Damaso, and P. F. Barroso. 2003. Accidental infection of laboratory worker with vaccinia virus. Emerg. Infect. Dis.9:724-726.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196701192760301"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.3.1207-1213.2004"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1976.8.issue-3.01"},{"key":"e_1_3_2_24_2","first-page":"459","volume":"338","year":"1991","unstructured":"Openshaw, P. J., W. H. Alwan, A. H. Cherrie, and F. M. Record. 1991. Accidental infection of laboratory worker with recombinant vaccinia virus. Lancet338:459.","journal-title":"Lancet"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2003.026781"},{"key":"e_1_3_2_26_2","first-page":"49","volume":"19","year":"1968","unstructured":"Potajallo, U., A. Towianska, and J. Dabrowski. 1968. Rate of inactivation of smallpox and vaccinia viruses by fixatives used in histological methods. Biul. Inst. Med. Morsk. Gdansk.19:49-57.","journal-title":"Biul. Inst. Med. Morsk. Gdansk."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/381205"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(03)00118-5"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.9.4602-4606.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.9.4602-4606.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T22:37:14Z","timestamp":1735943834000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.43.9.4602-4606.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1128\/JCM.43.9.4602-4606.2005"],"URL":"https:\/\/doi.org\/10.1128\/jcm.43.9.4602-4606.2005","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"type":"print","value":"0095-1137"},{"type":"electronic","value":"1098-660X"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"2005-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-06-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}